Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 21, 2023
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
Oren Livnat Reiterated (ANIP) at Strong Buy and Held Target at $50 on, Feb 21st, 2023
Oren Livnat of HC Wainwright & Co., Reiterated "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy and Held Target at $50 on, Feb 21st, 2023.
Oren, nor any peers, have made any analyst calls on ANIP in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30